Advances in the pharmacological activities and mechanisms of diosgenin

Gurib-Fakim, 2006, Medicinal plants: traditions of yesterday and drugs of tomorrow [J], Mol Aspects Med, 27, 1, 10.1016/j.mam.2005.07.008 Butler, 2005, Natural products to drugs: natural product derived compounds in clinical trials [J], Nat Prod Rep, 22, 162, 10.1039/b402985m Man, 2010, Chemical study and medical application of saponins as anti-cancer agents [J], Fitoterapia, 81, 703, 10.1016/j.fitote.2010.06.004 Shi, 2004, Saponins from edible legumes: chemistry, processing, and health benefits [J], J Med Food, 7, 67, 10.1089/109662004322984734 Djerassi, 1952, Steroids, XXVII. Synthesis of allopregnane-3beta, 11beta, 17alpha-, 20beta, 21-pentol from cortisone and diosgenin [J], J Biol Chem, 194, 115, 10.1016/S0021-9258(18)55859-2 Raju, 2008, Cancer chemopreventive and therapeutic effects of diosgenin, a food saponin [J], Nutr Cancer, 61, 27, 10.1080/01635580802357352 Yue, 2010, Recent advances of diosgenin in its pharmacological activities and mechanism [J], Chin J Clin Pharmacol Ther, 15, 233 Corbiere, 2003, Different contribution of apoptosis to the antiproliferative effects of diosgenin and other plant steroids, hecogenin and tigogenin, on human 1547 osteosarcoma cells [J], Int J Oncol, 22, 899 Corbiere, 2004, Induction of antiproliferative effect by diosgenin through activation of p53, release of apoptosis-inducing factor (AIF) and modulation of caspase-3 activity in different human cancer cells [J], Cell Res, 14, 188, 10.1038/sj.cr.7290219 Wang, 2014, The effects of diosgenin in the regulation of renal proximal tubular fibrosis [J], Exp Cell Res, 323, 255, 10.1016/j.yexcr.2014.01.028 Chen, 2011, Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression [J], PLos One, 6, e20164, 10.1371/journal.pone.0020164 He, 2014, Diosgenin inhibits the migration of human breast cancer MDA-MB-231 cells by suppressing Vav2 activity [J], Phytomedicine, 21, 871, 10.1016/j.phymed.2014.02.002 Mao, 2012, Anti-proliferation and anti-invasion effects of diosgenin on gastric cancer BGC-823 cells with HIF-1α shRNAs [J], Int J Mol Sci, 13, 6521, 10.3390/ijms13056521 Evan, 2001, Proliferation, cell cycle and apoptosis in cancer [J], Nature, 411, 342, 10.1038/35077213 Shishodia, 2005, Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, IκB kinase activation and NF-κB-regulated gene expression [J], Oncogene, 25, 1463, 10.1038/sj.onc.1209194 Chiang, 2007, Diosgenin, a naturally occurring steroid, suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt, mTOR and JNK phosphorylation [J], Febs Lett, 581, 5735, 10.1016/j.febslet.2007.11.021 Cailleteau, 2009, A proteomic approach to the identification of molecular targets in subsequent apoptosis of HEL cells after diosgenin-induced megakaryocytic differentiation [J], J Cell Biochem, 107, 785, 10.1002/jcb.22176 Raju, 2004, Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells [J], Cancer Epidemiol Biomarkers Prev, 13, 1392, 10.1158/1055-9965.1392.13.8 Mohammad, 2013, Diosgenin inhibits hTERT gene expression in the A549 lung cancer cell line [J], Asian Pac J Cancer Prev, 14, 6945, 10.7314/APJCP.2013.14.11.6945 Bian, 2011, Effects of diosgenin on cell proliferation induced by IGF-1 in primary human thyrocytes [J], Arch Pharm Res, 34, 997, 10.1007/s12272-011-0617-y Mu, 2012, Diosgenin induces apoptosis in IGF-1-stimulated human thyrocytes through two caspase-dependent pathways [J], Biochem Biophys Res Commun, 418, 347, 10.1016/j.bbrc.2012.01.024 Cai, 2014, Diosgenin relieves goiter via the inhibition of thyrocyte proliferation in a mouse model of Graves' disease [J], Acta Pharmacol Sini, 35, 65, 10.1038/aps.2013.133 Mani, 2008, The epithelial-mesenchymal transition generates cells with properties of stem cells [J], Cell, 133, 704, 10.1016/j.cell.2008.03.027 Zhou, 2014, Role of epithelial to mesenchymal transition proteins in gynecological cancers: pathological and therapeutic perspectives [J], Tumor Biology, 35, 9523, 10.1007/s13277-014-2537-1 Chang, 2011, Diosgenin suppresses hepatocyte growth factor (HGF)-induced epithelial-mesenchymal transition by down-regulation of Mdm2 and Vimentin [J], J Agric Food Chem, 59, 5357, 10.1021/jf200598w Gialeli, 2011, Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting [J], FEBS J, 278, 16, 10.1111/j.1742-4658.2010.07919.x Wang, 2005, Tumor cells caught in the act of invading: their strategy for enhanced cell motility [J], Trends Cell Biol, 15, 138, 10.1016/j.tcb.2005.01.003 Le Clainche, 2008, Regulation of actin assembly associated with protrusion and adhesion in cell migration [J], Physiol Rev, 88, 489, 10.1152/physrev.00021.2007 Rathinam, 2011, Role of Rho GTPases and their regulators in cancer progression [J], Front Biosci, 16, 2561, 10.2741/3872 Lin, 2004, Rho-regulatory proteins in breast cancer cell motility and invasion [J], Breast Cancer Res Treat, 84, 49, 10.1023/B:BREA.0000018424.43445.f3 Mihalache, 2014, Angiogenesis factors involved in the pathogenesis of colorectal cancer [J], Curr Health Sci J, 40, 5 Shimizu, 2012, The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer [J], Clin Cancer Res, 18, 2316, 10.1158/1078-0432.CCR-11-2381 Das, 2012, Antineoplastic and apoptotic potential of traditional medicines thymoquinone and diosgenin in squamous cell carcinoma [J], PLos One, 7, e46641, 10.1371/journal.pone.0046641 Srinivasan, 2009, Diosgenin targets Akt-mediated prosurvival signaling in human breast cancer cells [J], Int J Cancer, 125, 961, 10.1002/ijc.24419 Kim, 2012, Diosgenin induces apoptosis in HepG2 cells through generation of reactive oxygen species and mitochondrial pathway [J], Evid Based Complement Alternat Med, 2012, 981675, 10.1155/2012/981675 Liagre, 2005, Diosgenin, a plant steroid, induces apoptosis in COX-2 deficient K562 cells with activation of the p38 MAP kinase signalling and inhibition of NF-κB binding [J], Int J Mol Med, 16, 1095 Bertrand, 2008, Study of diosgenin-induced apoptosis kinetics in K562 cells by sedimentation field flow fractionation [J], J Chromatogr B, 869, 75, 10.1016/j.jchromb.2008.05.024 Yadav, 2010, Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer [J], Toxins, 2, 2428, 10.3390/toxins2102428 Shishodia, 2006, Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, IκB kinase activation and NF-κB-regulated gene expression [J], Oncogene, 25, 1463, 10.1038/sj.onc.1209194 Li, 2010, Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells [J], Cancer Lett, 292, 197, 10.1016/j.canlet.2009.12.003 Khan, 2011, Biology of Cox-2: an application in cancer therapeutics [J], Curr Drug Targets, 12, 1082, 10.2174/138945011795677764 Hsu, 2000, The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2 [J], J Biol Chem, 275, 11397, 10.1074/jbc.275.15.11397 Cailleteau, 2008, Increased cyclooxygenase-2 and thromboxane synthase expression is implicated in diosgenin-induced megakaryocytic differentiation in human erythroleukemia cells [J], Anal Biochem, 380, 26, 10.1016/j.ab.2008.05.026 Lepage, 2010, Cyclooxygenase-2 and 5-lipoxygenase pathways in diosgenin-induced apoptosis in HT-29 and HCT-116 colon cancer cells [J], Int J Oncol, 36, 1183 Lepage, 2011, Diosgenin induces death receptor-5 through activation of p38 pathway and promotes TRAIL-induced apoptosis in colon cancer cells [J], Cancer Lett, 301, 193, 10.1016/j.canlet.2010.12.003 Miyoshi, 2011, Chemoprevention of azoxymethane/dextran sodium sulfate-induced mouse colon carcinogenesis by freeze-dried Yam Sanyaku and its constituent diosgenin [J], Cancer Prev Res, 4, 924, 10.1158/1940-6207.CAPR-10-0279 Knudson, 2001, Two genetic hits (more or less) to cancer [J], Nat Rev Cancer, 1, 157, 10.1038/35101031 Menendez, 2007, Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis [J], Nat Rev Cancer, 7, 763, 10.1038/nrc2222 Baron, 2004, Fatty acid synthase: a metabolic oncogene in prostate cancer [J], J Cell Biochem, 91, 47, 10.1002/jcb.10708 Lee, 2013, Dysregulation of cholesterol homeostasis in human prostate cancer through loss of ABCA1 [J], Cancer Res, 73, 1211, 10.1158/0008-5472.CAN-12-3128 Guruswamy, 2008, Multi-target approaches in colon cancer chemoprevention based on systems biology of tumor cell-signaling [J], Gene Regul Syst Biol, 2, 163 DeBose-Boyd, 2008, Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase [J], Cell Res, 18, 609, 10.1038/cr.2008.61 Raju, 2007, Diosgenin, a naturally occurring furostanol saponin suppresses 3-hydroxy-3-methylglutaryl CoA reductase expression and induces apoptosis in HCT-116 human colon carcinoma cells [J], Cancer Lett, 255, 194, 10.1016/j.canlet.2007.04.011 Ebrahimi, 2014, Diosgenin attenuates inflammatory response induced by myocardial reperfusion injury: role of mitochondrial ATP-sensitive potassium channels [J], J Physiol Biochem, 70, 435, 10.1007/s13105-014-0320-9 Salimeh, 2013, Preconditioning with diosgenin and treadmill exercise preserves the cardiac toxicity of isoproterenol in rats [J], J Physiol Biochem, 69, 255, 10.1007/s13105-012-0208-5 Jayachandran, 2009, Antilipoperoxidative and membrane stabilizing effect of diosgenin, in experimentally induced myocardial infarction [J], Mol Cell Biochem, 327, 203, 10.1007/s11010-009-0058-9 Gutiérrez, 2013, Endothelial dysfunction over the course of coronary artery disease [J], Eur Heart J, 34, 3175, 10.1093/eurheartj/eht351 McVeigh, 1992, Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus [J], Diabetologia, 35, 771, 10.1007/BF00429099 Manivannan, 2013, Diosgenin improves vascular function by increasing aortic eNOS expression, normalize dyslipidemia and ACE activity in chronic renal failure rats [J], Mol Cell Biochem, 384, 113, 10.1007/s11010-013-1788-2 Liu, 2012, Diosgenin ameliorates palmitate-induced endothelial dysfunction and insulin resistance via blocking IKKβ and IRS-1 pathways [J], Atherosclerosis, 223, 350, 10.1016/j.atherosclerosis.2012.06.012 Dias, 2007, Mechanisms involved in the vasodilator effect induced by diosgenin in rat superior mesenteric artery [J], Eur J Pharmacol, 574, 172, 10.1016/j.ejphar.2007.07.017 Gong, 2010, Protective effects of diosgenin in the hyperlipidemic rat model and in human vascular endothelial cells against hydrogen peroxide-induced apoptosis [J], Chem-Biol Interact, 184, 366, 10.1016/j.cbi.2010.02.005 Au, 2004, Activation of iberiotoxin-sensitive, Ca2+ activated K+ channels of porcine isolated left anterior descending coronary artery by diosgenin [J], Eur J Pharmacol, 502, 123, 10.1016/j.ejphar.2004.08.045 Esfandiarei, 2011, Diosgenin modulates vascular smooth muscle cell function by regulating cell viability, migration, and calcium homeostasis [J], J Pharmacol Exp Ther, 336, 925, 10.1124/jpet.110.172684 Mayer, 2002, ω-3 Fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation [J], Am J Physiol-Heart C, 283, H811, 10.1152/ajpheart.00235.2002 Liu, 2014, Macrophage polarization in inflammatory diseases [J], Int J Biol Sci, 10, 520, 10.7150/ijbs.8879 Carlos, 1990, Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells [J], Blood, 76, 965, 10.1182/blood.V76.5.965.965 Ling, 2012, Cell adhesion molecules as pharmaceutical target in atherosclerosis [J], Mini-Rev Med Chem, 12, 175, 10.2174/138955712798995057 Choi, 2010, Inhibition of TNF-α-induced adhesion molecule expression by diosgenin in mouse vascular smooth muscle cells via down regulation of the MAPK, Akt and NF-κB signaling pathways [J], Vasc Pharmacol, 53, 273, 10.1016/j.vph.2010.09.007 Song, 2012, Diosgenin reduces leukocytes adhesion and migration linked with inhibition of intercellular adhesion molecule-1 expression and NF-κB p65 activation in endothelial cells [J], Chin J Nat Med, 10, 142, 10.3724/SP.J.1009.2012.00142 Drozdowska, 2011, Tissue factor in endothelial cells–its structure and function according to the current literature [J], Postepy Biochem, 58, 273 Åberg, 2013, Tissue factor non-coagulant signaling-molecular mechanisms and biological consequences with a focus on cell migration and apoptosis [J], J Thromb Haemost, 11, 817, 10.1111/jth.12156 Yang, 2013, Diosgenin inhibits tumor necrosis factor-induced tissue factor activity and expression in THP-1 cells via down-regulation of the NF-κB, Akt, and MAPK signaling pathways [J], Chin J Nat Med, 11, 608, 10.3724/SP.J.1009.2013.00608 Gong, 2011, Anti-thrombosis effect of diosgenin extract from Dioscorea zingiberensis CH Wright in vitro and in vivo [J], Phytomedicine, 18, 458, 10.1016/j.phymed.2010.08.015 Yan, 2006, Long-term high-fat diet induces pancreatic injuries via pancreatic microcirculatory disturbances and oxidative stress in rats with hyperlipidemia [J], Biochem Biophys Res Commun, 347, 192, 10.1016/j.bbrc.2006.06.063 Scheuer, 2000, Oxidant stress in hyperlipidemia-induced renal damage [J], Am J Physiol-Renal, 278, F63, 10.1152/ajprenal.2000.278.1.F63 Frohnert, 2013, Protein carbonylation, mitochondrial dysfunction, and insulin resistance [J], Adv Nutr, 4, 157, 10.3945/an.112.003319 Argani, 2004, Effect of lovastatin on lipid peroxidation and total antioxidant concentrations in hemodialysis patients [J], Lipids Health Dis, 3, 6, 10.1186/1476-511X-3-6 Kregel, 2007, An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations [J], Am J Physiol-Reg I, 292, R18 Czakó, 2007, Hyperlipidemia induced by a cholesterol-rich diet aggravates necrotizing pancreatitis in rats [J], Eur J Pharmacol, 572, 74, 10.1016/j.ejphar.2007.05.064 Son, 2007, Antioxidative and hypolipidemic effects of diosgenin, a steroidal saponin of yam (Dioscorea spp.), on high-cholesterol fed rats [J], Biosci Biotech Biochem, 71, 3063, 10.1271/bbb.70472 Manivannan, 2013, Diosgenin attenuates vascular calcification in chronic renal failure rats [J], Mol Cell Biochem, 378, 9, 10.1007/s11010-013-1588-8 Esser, 2014, Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes [J], Diabetes Res Clin Pract, 105, 141, 10.1016/j.diabres.2014.04.006 Uemura, 2011, Diosgenin, the main aglycon of fenugreek, inhibits LXRα activity in HepG2 cells and decreases plasma and hepatic triglycerides in obese diabetic mice [J], J Nutr, 141, 17, 10.3945/jn.110.125591 Sangeetha, 2013, PPAR's and diosgenin a chemico biological insight in NIDDM [J], Chem-Biol Interact, 206, 403, 10.1016/j.cbi.2013.08.014 Pari, 2012, Beneficial role of diosgenin on oxidative stress in aorta of streptozotocin induced diabetic rats [J], Eur J Pharmacol, 691, 143, 10.1016/j.ejphar.2012.06.038 Uemura, 2010, Diosgenin present in fenugreek improves glucose metabolism by promoting adipocyte differentiation and inhibiting inflammation in adipose tissues [J], Mol Nutr Food Res, 54, 1596, 10.1002/mnfr.200900609 Hirai, 2010, Diosgenin attenuates inflammatory changes in the interaction between adipocytes and macrophages [J], Mol Nutr Food Res, 54, 797, 10.1002/mnfr.200900208 Xiao, 2012, Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor mediated ERK1/2 activation to accelerate remyelination [J], Glia, 60, 1037, 10.1002/glia.22333 Girach, 2006, Diabetic microvascular complications-can the presence of one predict the development of another [J], J Diabetes Complicat, 20, 228, 10.1016/j.jdiacomp.2006.03.001 Cheng, 2009, Nerve growth factor mediates mechanical allodynia in a mouse model of type 2 diabetes [J], J Neuropath Exp Neur, 68, 1229, 10.1097/NEN.0b013e3181bef710 Kang, 2011, Diosgenin from Dioscorea nipponica ameliorates diabetic neuropathy by inducing nerve growth factor [J], Biol Pharm Bull, 34, 1493, 10.1248/bpb.34.1493 Kondeva-Burdina, 2007, In vitro effect of diosgenin, isolated from Asparagus officinalis, in a dopamine model of oxidative stress in isolated rat synaptosomes [J], Toxicol Lett, 172, S68, 10.1016/j.toxlet.2007.05.197 Chiu, 2011, Diosgenin ameliorates cognition deficit and attenuates oxidative damage in senescent mice induced by D-galactose [J], Am J Chin Med, 39, 551, 10.1142/S0192415X11009020 Tohda, 2013, Diosgenin-induced cognitive enhancement in normal mice is mediated by 1, 25D3-MARRS [J], Sci Rep, 3, 3395, 10.1038/srep03395 Wang, 2006, Diosgenin, a plant-derived sapogenin, stimulates Ca2+-activated K+ current in human cortical HCN-1A neuronal cells [J], Planta Med, 72, 430, 10.1055/s-2005-916260 Huang, 2010, Diosgenin, a plant-derived sapogenin, enhances regulatory T-cell immunity in the intestine of mice with food allergy [J], J Nat Prod, 73, 1033, 10.1021/np900690z Huang, 2009, Diosgenin attenuates allergen-induced intestinal inflammation and IgE production in a murine model of food allergy [J], Planta Med, 75, 1300, 10.1055/s-0029-1185578 Jan, 2007, Diosgenin, a steroidal sapogenin, enhances antigen-specific IgG2a and interferon-γ expression in ovalbumin-sensitized BALB/c mice [J], Planta Med, 73, 421, 10.1055/s-2007-967169 Ku, 2013, Anti-inflammatory effects of 27 selected terpenoid compounds tested through modulating Th1/Th2 cytokine secretion profiles using murine primary splenocytes [J], Food Chem, 141, 1104, 10.1016/j.foodchem.2013.04.044 Gao, 2013, Diosgenin down-regulates NF-κB p65/p50 and p38MAPK pathways and attenuates acute lung injury induced by lipopolysaccharide in mice [J], Int Immunopharmacol, 15, 240, 10.1016/j.intimp.2012.11.019 Jung, 2010, Diosgenin inhibits macrophage-derived inflammatory mediators through downregulation of CK2, JNK, NF-κB and AP-1 activation [J], Int Immunopharmacol, 10, 1047, 10.1016/j.intimp.2010.06.004 He, 2012, Anti-tumour and immunomodulating activities of diosgenin, a naturally occurring steroidal saponin [J], Nat Prod Res, 26, 2243, 10.1080/14786419.2011.648192 Conner, 2007, Breast response to menopausal hormone therapy-aspects on proliferation, apoptosis and mammographic density [J], Ann Med, 39, 28, 10.1080/07853890601039842 Komesaroff, 2001, Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women [J], Climacteric, 4, 144, 10.1080/cmt.4.2.144.150 Accatino, 1998, Effects of diosgenin, a plant-derived steroid, on bile secretion and hepatocellular cholestasis induced by estrogens in the rat [J], Hepatology, 28, 129, 10.1002/hep.510280118 Rao, 1992, Diosgenin-a growth stimulator of mammary gland of ovariectomized mouse [J], Indian J Exp Biol, 30, 367 Chiang, 2011, Osteoprotective effect of monascus-fermented dioscorea in ovariectomized rat model of postmenopausal osteoporosis [J], J Agric Food Chem, 59, 9150, 10.1021/jf201640j Higdon, 2001, The use of estrogen, DHEA, and diosgenin in a sustained delivery setting as a novel treatment approach for osteoporosis in the ovariectomized adult rat model [J], Biomed Sci Instrum, 37, 281 Yen, 2005, Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts [J], Mol Pharmacol, 68, 1061, 10.1124/mol.104.010082 Medigović, 2014, Diosgenin does not express estrogenic activity: a uterotrophic assay [J], Can J Physiol Pharm, 92, 292, 10.1139/cjpp-2013-0419 Hsu, 2008, Effects of yam and diosgenin on calpain systems in skeletal muscle of ovariectomized rats [J], Taiwan J Obstet Gynecol, 47, 180, 10.1016/S1028-4559(08)60077-7 Tada, 2009, Novel effects of diosgenin on skin aging [J], Steroids, 74, 504, 10.1016/j.steroids.2009.01.006 Lee, 2007, Diosgenin inhibits melanogenesis through the activation of phosphatidylinositol-3-kinase pathway (PI3K) signaling [J], Life Sci, 81, 249, 10.1016/j.lfs.2007.05.009 Zheng, 2014, Two new steroidal saponins from the rhizomes of Dioscorea zingiberensis [J], Chin J Nat Med, 12, 142 Noguchi, 2006, Metabolism of tomato steroidal glycosides in humans [J], Chem Pharm Bull, 54, 1312, 10.1248/cpb.54.1312